P9WKD3 (BLAC_MYCTU) Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
Beta-lactamase UniProtKBInterProSTRINGInteractive Modelling
307 aa; Sequence (Fasta) ;
13 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
73 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Beta-Lactamase, 100ms timepoint, mixed, shards crystal form | homo-4-mer | 100 | 2×PO4; 4×9F2; 1×FZS; | |||
| Beta-Lactamase, 500ms timepoint, mixed, shards crystal form | homo-4-mer | 100 | 2×PO4; 4×9F2; 1×CUG; 1×FZS; | |||
| XFEL structure of Mycobacterium tuberculosis beta lactamase microcrystals | homo-4-mer | 100 | 4×PO4; | |||
| Beta-Lactamase, 2secs timepoint, mixed, shards crystal form | homo-4-mer | 100 | 2×PO4; 4×9F2; 2×FZS; | |||
| XFEL structure of Mycobacterium tuberculosis beta lactamase microcrystals mixed with sulbactam for … | homo-4-mer | 100 | 4×PO4; 4×TSL; | |||
| XFEL structure of Mycobacterium tuberculosis beta lactamase microcrystals mixed with sulbactam for … | homo-4-mer | 100 | 4×PO4; | |||
| XFEL structure of beta lactamase microcrystals mixed with sulbactam solution for 15ms | homo-4-mer | 100 | 4×PO4; 2×TSL; | |||
| Cryo structure of Mycobacterium tuberculosis beta lactamase microcrystals mixed with sulbactam for … | homo-4-mer | 100 | 4×PO4; 4×TSL; | |||
| XFEL structure of Mycobacterium tuberculosis beta lactamase microcrystals mixed with sulbactam for … | homo-4-mer | 100 | 4×PO4; | |||
| XFEL structure of Mycobacterium tuberculosis beta lactamase microcrystals mixed with sulbactam for … | homo-4-mer | 100 | 4×PO4; 2×0RN; 2×TSL; | |||
| XFEL structure of Mycobacterium tuberculosis beta lactamase microcrystals mixed with sulbactam for … | homo-4-mer | 100 | 4×PO4; 4×TSL; | |||
| Structure of P107T BlaC from Mycobacterium tuberculosis | homo-2-mer | 100.0 | 3×PO4; 1×GOL; | |||
| Structure of G132N BlaC from Mycobacterium tuberculosis | monomer | 99.62 | 2×GOL; 16×EDO; 2×PO4; 1×NA; | |||
| Crystal Structure of beta-lactamase from M.tuberculosis forming Michaelis Menten with Tebipenem | monomer | 99.62 | 4×PO4; 1×1TE; | |||
| X-ray structure of the full-length beta-lactamase from M.tuberculosis | monomer | 100 | 5×SO4; | |||
| Crystal Structure of BlaC-K73A bound with Cefamandole | monomer | 99.62 | 1×PO4; 5×SMX; | |||
| Crystal Structure of the Ertapenem Pre-isomerized Covalent Adduct with TB B-lactamase | monomer | 100 | 2×PO4; 2×1RG; | |||
| Structure of P226G BlaC from Mycobacterium tuberculosis | monomer | 99.62 | 8×GOL; 1×EDO; 2×PO4; | |||
| Structure of G132S BlaC from Mycobacterium tuberculosis bound to the trans-enamine adduct of sulbac… | monomer | 99.62 | 1×TSL; 3×GOL; 1×ACT; | |||
| Crystal structure of A55E mutant of BlaC from Mycobacterium tuberculosis | monomer | 99.62 | 9×GOL; 1×PO4; | |||
| Structure of D172N BlaC from Mycobacterium tuberculosis | monomer | 99.62 | 5×EDO; | |||
| Crystal Structure of BlaC-E166A covalently bound with Ampicillin | monomer | 99.62 | 2×PO4; 1×AIX; | |||
| Structure of G132S BlaC from Mycobacterium tuberculosis | monomer | 99.62 | 2×TRS; 5×GOL; 3×SO4; | |||
| Crystal Structure of BlaC-E166A covalently bound with Carbenicillin | monomer | 99.62 | 1×PO4; 1×CB9; | |||
| Structure of E166A BlaC from Mycobacterium tuberculosis at pH 4.5 | monomer | 99.62 | 2×SO4; | |||
| Crystal Structure of BlaC-E166A covalently bound with Mecillinam | monomer | 99.62 | 3×PO4; 1×DH4; | |||
| Structure of E37A BlaC from Mycobacterium tuberculosis | monomer | 99.62 | ||||
| Phosphoserine BlaC, Class A serine beta-lactamase from Mycobacterium tuberculosis | monomer | 100 | 2×PO4; | |||
| Structure of S70C BlaC from Mycobacterium tuberculosis | monomer | 99.62 | 1×EDO; 1×PG0; | |||
| Crystal Structure of the Covalent Adduct Formed between TB B-lactamase and Clavulanate | monomer | 100 | 4×PO4; 1×ISS; | |||
| Crystal Structure of BlaC-E166A covalently bound with Cephalotin | monomer | 99.62 | 2×PO4; 1×9EP; | |||
| Crystal Structure of BlaC-E166A covalently bound with Amoxicillin | monomer | 99.62 | 1×AXL; 2×PO4; | |||
| Crystal structure of the Mycobacterium tuberculosis beta-lactamase | monomer | 100 | ||||
| Structure of D179N BlaC from Mycobacterium tuberculosis | monomer | 99.62 | ||||
| Beta-Lactamase, unmixed needles crystal form | monomer | 100 | ||||
| Meropenem Covalent Adduct with TB Beta-lactamase | monomer | 100 | 2×PO4; 1×DWZ; | |||
| Beta-Lactamase, mixed with Ceftriaxone, needles crystal form, 100ms | monomer | 100 | 1×FZS; 1×9F2; | |||
| Structure of BlaC from Mycobacterium tuberculosis at pH 8 | monomer | 100 | 1×GOL; | |||
| Structure of P167S BlaC from Mycobacterium tuberculosis at pH 6.3 | monomer | 99.62 | 2×GOL; 1×FLC; | |||
| Structure of M.Tuberculosis Betalactamase (Blac) with inhibitor having novel mechanism | monomer | 100 | 1×33V; 2×PO4; | |||
| Crystal Structure of BlaC-E166A covalently bound with Methicillin | monomer | 99.62 | 2×PO4; 1×7EP; | |||
| Structure of D179N BlaC from Mycobacterium tuberculosis in complex with vaborbactam | monomer | 99.62 | 1×4D6; 4×GOL; 2×PO4; 1×NA; | |||
| Beta-Lactamase, mixed with Ceftriaxone, needles crystal form, 30ms | monomer | 100 | 1×9F2; | |||
| Structure of P167S BlaC from Mycobacterium tuberculosis at pH 5 | monomer | 99.62 | 1×GOL; | |||
| Beta-Lactamase, mixed with Ceftriaxone, needles crystal form, 500ms | monomer | 100 | 1×FZS; 1×9F2; | |||
| Crystal Structure of beta-lactamase from M.tuberculosis covalently complexed with Tebipenem | monomer | 100 | 1×TEB; 4×PO4; | |||
| Structure of D179N BlaC from Mycobacterium tuberculosis bound to the trans-enamine adduct of sulbac… | monomer | 99.62 | 1×TSL; 2×GOL; 2×PO4; | |||
| Structure of BlaC from Mycobacterium tuberculosis in complex with vaborbactam | monomer | 100 | 1×4D6; 6×PO4; 5×GOL; | |||
| Crystal Structure of Post-isomerized Ertapenem Covalent Adduct with TB B-lactamase | monomer | 100 | 2×PO4; 1×2RG; | |||
| Crystal Structure of BlaC-E166A covalently bound with 6-aminopenicillian | monomer | 99.62 | 1×XD1; 2×PO4; | |||
| Crystal Structure of BlaC-E166A covalently bound with Cefamandole | monomer | 99.62 | 2×PO4; 1×XD2; | |||
| Crystal Structure of BlaC-E166A covalently bound with Cefuroxime | monomer | 99.62 | 1×DXF; | |||
| Beta-Lactamase, mixed with Ceftriaxone, needles crystal form, 2sec | monomer | 100 | 1×9F2; | |||
| Inhibitor resistant (R220A) substitution in the Mycobacterium tuberculosis beta-lactamase | monomer | 99.62 | 5×PO4; | |||
| Crystal structure of BlaC from Mycobacterium tuberculosis | monomer | 100 | 4×ACT; 1×GOL; 1×PGE; | |||
| BlaC E166A Faropenem Acyl-Intermediate Complex | monomer | 99.62 | 3×PO4; | |||
| Crystal Structure of BlaC covalently bound with Doripenem | monomer | 100 | 2×PO4; 1×DRW; | |||
| Crystal Structure of the inhibitor NXL104 Covalent Adduct with TB B-lactamase | monomer | 100 | 2×PO4; 1×NXL; | |||
| BlaC E166A Cefotaxime Acyl-Intermediate Complex | monomer | 99.62 | 4×PO4; | |||
| Structure of E166A BlaC from Mycobacterium tuberculosis at pH 6.5 | monomer | 99.62 | ||||
| Beta-lactamase mixed with Ceftriaxone, 5ms | monomer | 100 | 1×PO4; | |||
| Beta-Lactamase, unmixed shards crystal form | monomer | 100 | 1×PO4; | |||
| BlaC E166A CDC-1 Acyl-Intermediate | monomer | 99.62 | 3×PO4; | |||
| Beta-lactamase mixed with Ceftriaxone, 10ms | monomer | 100 | 1×PO4; | |||
| Beta-lactamase mixed with Ceftriaxone, 50ms | monomer | 100 | 1×PO4; 1×9F2; | |||
| Beta-lactamase mixed with Sulbactam, 60ms | monomer | 100 | 1×0RN; 1×PO4; | |||
| Beta-lactamase, mixed with Ceftriaxone, 30ms time point, Shards crystal form | monomer | 100 | 1×PO4; 1×9F2; | |||
| BlaC E166A CDC-OMe Acyl-Intermediate Complex | monomer | 99.62 | 1×CD8; | |||
| Crystal Structure of BlaC-E166A covalently bound with Nafcillin | monomer | 100.0 | 1×NFF; | |||
| Beta-lactamase, Unmixed | monomer | 100 | 1×PO4; | |||
| BlaC Amoxicillin Acyl-Intermediate Complex | monomer | 99.62 | 3×PO4; | |||
| Crystal structure of BlaC from Mycobacterium tuberculosis bound to phosphate | monomer | 100 | 1×PO4; 3×ACT; | |||
| M.tuberculosis betalactamase complexed with inhibitor EC19 | monomer | 99.24 | 7×PO4; 1×3Y6; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3zhh.1.A | monomer | 0.93 | 100.00 | |||